| Applications: | Immunodepletion/Immunocompetition |
| Note: | STRICTLY FOR FURTHER SCIENTIFIC RESEARCH USE ONLY (RUO). MUST NOT TO BE USED IN DIAGNOSTIC OR THERAPEUTIC APPLICATIONS. |
| Short Description : | Luteinizing Hormone Blocking Peptide for STJ501602 is synthetically produced from the 100-136 sequence and is suitable for use in western blot applications. |
| Formulation: | Liquid form at 2.5mg/ml concentration in PBS. Up to 5% DMSO can be added. Orders with >1mg can be supplied in lyophilized powder form, or in buffer of choice. |
| Dilution Range: | WB: IHC: 1:250ICC: 1:250IF: 1:250CFM: 1:250 |
| Storage Instruction: | Store at-20°C for long term storage. Avoid freeze-thaw cycles. |
| Immunogen Region: | 100-136 |
| Specificity: | This blocking peptide is recommended for use in combination with Luteinizing Hormone antibody, STJ501602 |
| Immunogen: | Synthetic peptide taken within amino acid region 100-136 on human Luteinizing hormone beta subunit. |
| Background | Promotes spermatogenesis and ovulation by stimulating the testes and ovaries to synthesize steroids. |
Information sourced from Uniprot.org